Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Sell
3,927
-129
-3% -$15.1K 0.17% 120
2026
Q1
$488K Buy
4,056
+17
+0.4% +$1.96K 0.19% 116
2025
Q4
$425K Sell
4,039
-574
-12% -$53.9K 0.16% 120
2025
Q3
$387K Buy
4,613
+149
+3% +$12.3K 0.15% 126
2025
Q2
$353K Sell
4,464
-5,688
-56% -$452K 0.15% 127
2025
Q1
$911K Sell
10,152
-3,114
-23% -$291K 0.47% 71
2024
Q4
$1.32M Buy
+13,266
New +$1.37M 0.73% 40

Other funds holding MRK

Crux Wealth Advisors's MRK Position: Q2 2026 in Review

Crux Wealth Advisors reduced its Merck (MRK) stake by 3.2% in Q2 2026, selling an estimated $15.1K and leaving 3,927 shares worth $505K. The position accounts for 0.17% of the portfolio, ranked #120.

Crux Wealth Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.32M in Q4 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Crux Wealth Advisors held 3,927 shares of Merck worth $505K as of Q2 2026.
  • Crux Wealth Advisors sold 129 Merck shares in Q2 2026, an estimated $15.1K.
  • Merck made up 0.17% of Crux Wealth Advisors's portfolio in Q2 2026, its #120 holding.
  • Crux Wealth Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Crux Wealth Advisors's Merck position peaked at $1.32M in Q4 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Crux Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.